More Medicare beneficiaries are not taking prescribed medications or forgoing basic needs to pay for them, a new study finds.
New research raises complicated questions about the value of an alternative to traditional Medicare.
Starting in January, Medicare will pay monthly fees to doctors who manage care for patients with two or more chronic conditions like heart disease, diabetes and depression.
Only a fraction of an estimated $60 billion in fraud and overcharging was recovered last year, and the system to combat fraud may be largely to blame.
Experts question the effectiveness of H.P. Acthar Gel, a drug made from pigs’ pituitary glands. Yet it cost Medicare more than $141 million in 2012, up from $7 million in 2008.
The top four prescribers of the drug were promotional speakers, researchers or consultants.
As medical groups debate a report finding shortcomings in doctor training programs, what’s missing is talk of lack of oversight in such programs, which receive generous public funding.
The Affordable Care Act is reaching many people who have not had health insurance in years, if at all, and they are struggling to understand their policies.
Health care experts can’t explain the encouraging spending slowdown, but the long-term outlook remains bleak.
Spending on hospital care was lower than expected, but trustees say Medicare and Social Security funds need shoring up.
Notes on the House Budget Chairman’s latest proposals.
Modeling a Medicare plan on the Affordable Care Act could save taxpayers money by forcing plans to compete on price rather than unnecessary benefits.
The deficit scolds are still going at it, even though the whole panic turned out to be a false alarm.
State insurance regulators and the Obama administration plan to revise standards so consumers will encounter fewer unexpected out-of-network bills.
On a small movement’s genuinely big ideas.